Showing results (731-740 of 1,383) with videos related to
Sort By:
Pageof 139
ACS Pharmacology & Translational Science|December 20, 2021
Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in OncologyNatalia Sacilotto, Paola Dessanti, Michele M P Lufino, et al.ACS Pharmacology & Translational Science|December 20, 2021
G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in HepatocytesLi-Chiung Lin, Tezz Quon, Susanna Engberg, et al.ACS Pharmacology & Translational Science|March 4, 2021
Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using 1H NMR SpectroscopyJack E Bramham, Adrian Podmore, Stephanie A Davies, et al.ACS Pharmacology & Translational Science|September 16, 2022
Monomerization of Homodimeric Trefoil Factor 3 (TFF3) by an Aminonitrile Compound Inhibits TFF3-Dependent Cancer Cell SurvivalVijay Pandey, Xi Zhang, Han-Ming Poh, et al.ACS Pharmacology & Translational Science|September 16, 2022
Using Human Serum Albumin Binding Affinities as a Proactive Strategy to Affect the Pharmacodynamics and Pharmacokinetics of Preclinical Drug CandidatesJianwei Fan, Katherine Gilmartin, Steven Octaviano, et al.ACS Pharmacology & Translational Science|September 16, 2022
Therapeutic Targeting of Cancer Stem Cells Prevents Resistance of Colorectal Cancer Cells to MEK InhibitionAstha Lamichhane, Pradip Shahi Thakuri, Sunil Singh, et al.ACS Pharmacology & Translational Science|October 21, 2022
Effects of Purinergic Receptor Deletion or Pharmacologic Modulation on Pulmonary Inflammation in MiceGregory S Whitehead, Tadeusz P Karcz, Dilip K Tosh, et al.ACS Pharmacology & Translational Science|October 21, 2022
Synthesis of Morpholine-, Piperidine-, and N-Substituted Piperazine-Coupled 2-(Benzimidazol-2-yl)-3-arylquinoxalines as Novel Potent Antitumor AgentsVakhid A Mamedov, Nataliya A Zhukova, Alexandra D Voloshina, et al.ACS Pharmacology & Translational Science|October 21, 2022
Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening AssayEddy E Alfonso, Zifang Deng, Daniel Boaretto, et al.ACS Pharmacology & Translational Science|October 21, 2022
Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein DegradationCamilla Ruffilli, Sascha Roth, Monica Rodrigo, et al.Pageof 139